BackYumanity Therapeutics Overview

Yumanity Therapeutics Selling, General & Admin

Explore Yumanity Therapeutics's selling, general & admin with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$1.40M
61.88% YoY

As of Mar 31, 2025

Annual SG&A Expenses (TTM)

$4.32M
63.69% YoY

Trailing 12 months ending Mar 31, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Yumanity Therapeutics (YMTX) FAQ

Stockcircle tracks selling, general & admin for Yumanity Therapeutics (YMTX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for Yumanity Therapeutics's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main YMTX overview so you can move from this figure to the surrounding analysis quickly.